Related by context. All words. (Click for frequent words.) 69 serum urate levels 68 autoantibody levels 68 intensive statin therapy 68 intravascular hemolysis 68 colorectal adenoma 68 neutrophil counts 68 HER2 overexpression 67 RBP4 levels 67 complete cytogenetic response 67 serum urate 67 rosuvastatin #mg 67 morphometric vertebral fractures 67 Natalizumab 66 postoperative mortality 66 glycated hemoglobin levels 66 endometrial hyperplasia 66 prednisone prednisolone 66 symptomatic VTE 66 viral titers 66 reinfarction 66 thrombotic complications 65 serum calcium levels 65 HbA 1c levels 65 adenoma recurrence 65 PASI scores 65 diabetic kidney 65 canakinumab 65 riociguat 65 serum clusterin levels 65 A1c levels 65 glycosylated hemoglobin HbA1c 65 serum uric acid sUA 65 angiographic restenosis 65 paricalcitol 65 EBV infection 65 Interferon beta 1b 65 antitumor efficacy 64 nephrotoxicity 64 neurocognitive deficits 64 renal flares 64 virological response 64 teriflunomide 64 oral FTY# 64 serum cortisol 64 deferiprone 64 fenretinide 64 glomerular filtration 64 haematologic 64 bezafibrate 64 urate levels 64 rimonabant #mg 64 homocysteine concentrations 64 serum BDNF 64 serum phosphate levels 64 transaminase levels 64 radiographic progression 64 myocardial reperfusion 64 lymphocyte counts 64 arterial stiffening 64 interferon ribavirin 64 PSADT 64 aminotransferases 64 biochemical relapse 64 triglyceride concentrations 64 hepatic fibrosis 64 flutamide 64 CPAP adherence 64 Hypotension 64 CLA supplementation 64 leukocyte counts 64 pCR 64 Hydroxyurea 64 renal toxicity 63 induce orthostatic hypotension 63 statins cholesterol lowering 63 platelet reactivity 63 TNF antagonist 63 CIMZIA ™ 63 eculizumab therapy 63 endometrial carcinoma 63 antihypertensive therapy 63 antiandrogen 63 steroid dexamethasone 63 ovarian suppression 63 glycosylated hemoglobin levels 63 Thal Dex 63 rufinamide 63 elevated triglyceride levels 63 cerebral vasospasm 63 STRIDE PD 63 ZOLINZA 63 Subgroup analysis 63 intensive lipid lowering 63 dosing frequency 63 systemic toxicity 63 HIV HCV coinfected 63 antioxidant supplementation 63 PSA nadir 63 clazosentan 63 lowering homocysteine 63 clomipramine 63 H. pylori eradication 63 ATACAND 63 probiotic supplementation 63 recurrent venous thromboembolism 63 AST ALT 63 beta blocker therapy 63 plasma triglycerides 63 serum phosphate 63 β blockers 63 CCyR 63 p# activation 63 AGILECT R 63 hypoperfusion 63 cardiac toxicity 63 platelet inhibition 63 symptomatic intracranial 63 EXJADE 63 nocturnal hypoglycaemia 63 salmeterol fluticasone 63 serum creatinine levels 63 iniparib 63 RSV hospitalizations 63 hematologic parameters 63 annualized relapse 63 ventricular tachyarrhythmia 63 vasodilatation 63 mitoxantrone plus 63 hematological toxicity 63 platelet activation 63 intravenous cyclophosphamide 63 pentoxifylline 63 COPD exacerbations 63 atheroma volume 63 intima media thickness 63 pyridostigmine 63 hemoglobin A1c levels 63 antithrombotic therapy 63 lung metastasis 63 antidiabetic medication 63 atherogenic dyslipidemia 63 blood glucose concentrations 63 bardoxolone methyl 63 hyperalgesia 63 DFMO 63 serum homocysteine 63 eplerenone 63 hypercholesterolemic patients 63 impair fertility 62 hepatic toxicity 62 doxorubicin docetaxel 62 avosentan 62 cardiac dysfunction 62 urinary excretion 62 parkinsonian symptoms 62 CYP#D# inhibitor 62 MGd 62 ARB telmisartan 62 Femara letrozole 62 Teriflunomide 62 Darapladib 62 Xelox 62 salivary flow 62 tumor necrosis 62 CDI recurrence 62 postoperative atrial fibrillation 62 gout flares 62 ACTEMRA TM 62 VADT 62 olmesartan 62 hyperphenylalaninemia HPA due 62 intravenous bisphosphonates 62 CYT# potent vascular disrupting 62 asymptomatic carotid stenosis 62 invasive candidiasis 62 antiplatelet agent 62 artery stenosis 62 liver metastasis 62 infarct size 62 CETP inhibition 62 recurrent VTE 62 ischemia induced 62 Adjuvant chemotherapy 62 Arranon 62 anakinra 62 AA Amyloidosis 62 serum aminotransferase levels 62 severe exacerbations 62 thyrotropin levels 62 relapsed MM 62 clodronate 62 paraprotein 62 corticosteroid dose 62 nocturnal hypoglycemia 62 donepezil Aricept 62 antibiotic rifaximin 62 baseline HbA1c 62 cranial irradiation 62 Thalomid ® 62 evaluating tivozanib 62 genital herpes infections 62 polyp recurrence 62 postoperative pulmonary 62 postoperative morbidity 62 divalproex sodium 62 postoperative AF 62 untreated OSA 62 revascularizations 62 plasma homocysteine 62 cilostazol 62 tamoxifen Nolvadex ® 62 hemorrhagic complications 62 trastuzumab Herceptin ® 62 bronchial inflammation 62 moderate renal impairment 62 prolonged QT interval 62 dopaminergic therapy 62 cardiotoxic 62 microvascular complications 62 corticosteroid dexamethasone 62 conventional DMARDs 62 Erythropoietic therapies may 62 androgen suppression 62 myopathy rhabdomyolysis 62 triiodothyronine 62 metastatic malignant 62 PAOD 62 airway hyper responsiveness 62 plasma HCV RNA 62 blood Phe levels 62 INCB# [003] 62 LV dysfunction 62 adalimumab Humira 62 symptomatic intracranial hemorrhage 62 BYSTOLIC 62 Cardiotoxicity 62 eosinophil count 62 tumor regressions 62 hsCRP levels 62 serum LDL cholesterol 62 hippocampal atrophy 62 paroxetine Paxil 62 cardiac repolarization 62 nerve degeneration 62 myocardial infarct size 62 TNF alpha antagonist 62 IFN beta 62 extrapyramidal symptoms 61 mepolizumab 61 nucleotide analog 61 severe hypoglycaemia 61 postprocedure 61 thrombocytopenic patients 61 ApoA1 61 selegiline 61 recurrent genital herpes 61 adiponectin levels 61 ancrod 61 deferasirox 61 recurrent glioblastoma multiforme 61 acute gout flares 61 virologic failure 61 sitaxsentan 61 cediranib 61 glucosylceramide 61 androgen ablation 61 arterial inflammation 61 prostate carcinogenesis 61 Procoralan 61 antigen PSA levels 61 REMINYL ® 61 systemic corticosteroid 61 antibody titer 61 edifoligide 61 midstage clinical 61 brain lesions 61 MULTAQ 61 erythema redness 61 intraocular pressure IOP 61 TMP SMX 61 Oral corticosteroids 61 Cinquil 61 elevated IOP 61 mycophenolate mofetil 61 Telintra 61 cardiovascular disease hypertension 61 corticosteroid therapy 61 fosamprenavir 61 myocardial necrosis 61 inflammatory biomarkers 61 growth hormone secretion 61 adrenal function 61 MMP inhibitor 61 ximelagatran 61 fetal malformations 61 CIPN 61 serum estradiol 61 lowering blood glucose 61 PHPT 61 prospectively stratified 61 Ribavirin causes 61 intensity allogeneic stem 61 albumin excretion rate 61 mitochondrial toxicity 61 rHuEPO 61 anti androgen 61 EGFRIs 61 Bosentan 61 BARACLUDE ® 61 Diamyd r vaccine 61 interferon beta therapy 61 Platelet counts 61 neurodevelopmental outcomes 61 refractory ischemia 61 hematological parameters 61 foveal thickness 61 mycophenolic acid 61 aromatase inhibitor therapy 61 microglial activation 61 Hb A1C 61 ruboxistaurin 61 dose dependently 61 rituximab Rituxan 61 baseline LDH 61 receptor inhibitor 61 clopidogrel Plavix 61 antiplatelet drugs 61 venlafaxine Effexor 61 protease inhibitors PIs 61 selenium supplementation 61 MAGE A3 ASCI 61 liver scarring 61 T1DM 61 maximal doses 61 QTc prolongation 61 amyloid β 61 hyperprolactinemia 61 carbohydrate absorption 61 VEGF inhibition 61 Dasatinib 61 BRAF inhibitor 61 Cholinesterase inhibitors 61 antiplatelet medications 61 octreotide LAR 61 losartan 61 KRAS mutant tumors 61 plasma glucose levels 61 salmeterol HFA MDI 61 activated microglia 61 SUVmax 61 #mg dose [002] 61 SHBG levels 61 verapamil 61 CIN3 61 fluticasone salmeterol 61 capillary leakage 61 concomitant medications 61 glycated hemoglobin HbA1c 61 thyrotropin 61 tranylcypromine 61 vidofludimus 61 microvascular disease 61 prolongs survival 61 LNG IUS 61 neurodevelopmental outcome 61 anterior uveitis 61 prolactin elevation 61 ovarian hormones 61 Hepatotoxicity 61 FASLODEX 61 CYP #A# 61 antitumor effect 61 circulating lymphocytes 61 AChE inhibitors 61 EDARBI 61 Drug eluting stent 61 rFVIIa 61 serum uric acid 61 dexrazoxane 61 curative resection 61 serum triglyceride levels 61 carotid atherosclerosis 61 tibolone 61 alteplase 61 Crestor rosuvastatin 61 PLX STROKE targeting 60 pegaptanib 60 arterial thromboembolic events 60 proliferative diabetic retinopathy 60 tolvaptan 60 anagrelide 60 ß amyloid 60 genotypic resistance 60 alanine aminotransferase ALT 60 vaso occlusive crisis 60 apneic episodes 60 deep venous thromboses 60 simvastatin ezetimibe 60 Insulin sensitivity 60 Safinamide 60 irbesartan 60 hepatic insulin sensitivity 60 retransplantation 60 coagulation parameters 60 cholinesterase inhibitor 60 dose atorvastatin 60 IOP lowering 60 lactate dehydrogenase LDH 60 polyp detection 60 subclinical inflammation 60 candesartan cilexetil 60 periprocedural 60 hypophosphatemia 60 lumiliximab 60 bronchopulmonary dysplasia 60 trials RCTs 60 cardiac contractility 60 Stent thrombosis 60 Combination therapy 60 RAS blockers 60 lactate dehydrogenase 60 Retreatment 60 agomelatine 60 HER2 expression 60 cisplatin chemotherapy 60 antiangiogenic agents 60 elotuzumab 60 systemic hypotension 60 amisulpride 60 recurrent ischemia 60 VA# [002] 60 sitosterol 60 fibrin deposition 60 oxycodone CR 60 carotid IMT 60 VEGF expression 60 myeloperoxidase 60 leucopenia 60 pressure natriuresis 60 Decitabine 60 amyloid plaque formation 60 lamotrigine 60 idraparinux 60 postoperative delirium 60 treprostinil 60 postoperative chemotherapy 60 DAPT 60 Ceplene/IL-2 60 VEGF inhibitors 60 neovascular 60 dose colchicine 60 HbA1c levels 60 achieved ACR# 60 ginkgo biloba extract 60 eosinophilia 60 upper gastrointestinal bleeding 60 IV bisphosphonates 60 erlotinib Tarceva 60 hemoglobin A1c HbA1c 60 prolactin levels 60 neurocognitive outcomes 60 vestibular schwannomas 60 Hematologic 60 oral antidiabetes 60 levodopa therapy 60 tarenflurbil 60 uric acid levels 60 losartan Cozaar 60 binary restenosis 60 proliferative retinopathy 60 hydroxychloroquine 60 durable remissions 60 proton MR spectroscopy 60 DITPA 60 Losartan 60 pravastatin Pravachol 60 galiximab 60 dopamine antagonists 60 prostate cancer CaP 60 lichen planus 60 leukotriene receptor antagonist 60 RoACTEMRA 60 EGFR TKI 60 timepoints 60 phase IIb trial 60 intestinal permeability 60 APTIVUS r 60 candesartan 60 chromium supplementation 60 platelet clumping 60 ACZ# 60 Bifeprunox 60 NATRECOR R 60 hepatic enzymes 60 amyloid deposition 60 allogeneic HSCT 60 mucosal healing 60 hypoglycemic episodes 60 adjuvant radiation 60 ImmunoVEX HSV2 60 squamous cell lung cancer 60 abacavir lamivudine 60 QTcF 60 leflunomide 60 genital ulcers 60 beta interferons 60 macrovascular 60 CP CPPS 60 frataxin 60 aminotransferase levels 60 imexon 60 fumagillin nanoparticles 60 urate lowering therapy 60 tirofiban 60 uric acid lowering 60 raloxifene Evista 60 invasive ductal 60 pegylated liposomal doxorubicin 60 Alequel 60 secondary efficacy endpoint 60 troponin T 60 Non inferiority 60 gamma secretase inhibitor 60 antibody mediated 60 Tekamlo 60 resected pancreatic cancer 60 atrioventricular block 60 OHR/AVR# 60 intracranial stenosis 60 HIV lipodystrophy 60 CYP#A# substrate 60 APTIVUS R 60 perioperative morbidity 60 reboxetine 60 #.#/#.# mmHg [001] 60 neural degeneration 60 reflux symptoms 60 gastrointestinal absorption 60 ACTOS ® 60 Tasigna prolongs 60 antiangiogenic therapy 60 lipid lowering medications 60 carotid artery thickness 60 mL/min/#.# m 2 60 VIIBRYD 60 hydralazine 60 axonal damage 60 Atrasentan 60 enalapril 60 Vorapaxar 60 collagen degradation 60 RISPERDAL ® 60 ibandronate 60 HbF 60 cancerous colon polyps 60 INVEGA ® 60 aciclovir 60 invasive aspergillosis 60 hyperglycaemia 60 potassium sparing diuretics 60 haemolysis 60 symptom flare ups 60 hematopoietic cancers 60 aspirin clopidogrel 60 rosuvastatin Crestor 60 adjuvant radiotherapy 60 sargramostim 60 preterm deliveries 60 d4T stavudine Zerit 60 fibrinolysis 60 everolimus eluting stents 60 sulfasalazine 60 protein excretion 60 allergic inflammation 60 dysmenorrhoea 60 TPV r 60 aldosterone antagonists 60 fatty acid oxidation 60 colorectal carcinoma 60 sulphonylureas 60 Glatiramer acetate 60 lung fibrosis 60 Endothelial function 60 ductal cancer 60 cortisol secretion 60 oral methylnaltrexone 60 paroxysmal AF 60 low dose ritonavir 60 postoperative ileus 60 RAS mutations 60 virologic response 60 xanthine oxidase inhibitor 60 acromegalic patients 60 antidepressant efficacy 60 pulmonary exacerbation 60 opioid analgesia 60 vismodegib 60 intracranial hemorrhage ICH 60 thromboembolic disease 60 aspartate aminotransferase AST 60 Fingolimod 60 thalidomide Thalomid 60 Zevalin consolidation 60 pharmacokinetic interactions 60 magnesium intake 60 DAS# CRP 60 ziconotide 60 inhaled budesonide 60 rebleeding 60 intimal hyperplasia 60 hematologic toxicity 60 fibrate drugs 60 orofacial clefts 60 variceal hemorrhage 59 inducible nitric oxide synthase 59 Fasting plasma glucose 59 HBeAg seroconversion 59 cetuximab Erbitux 59 chemosensitivity 59 oral corticosteroids 59 phytoestrogen intake 59 aldosterone antagonist 59 tic severity 59 serum sodium levels 59 airway hyperresponsiveness 59 T2 lesions 59 OAB symptoms 59 BMPR2 59 antiplatelet medication 59 Alzheimer Disease AD 59 Kinoid 59 ocrelizumab 59 HDL LDL ratio 59 panitumumab Vectibix 59 gemifloxacin 59 etanercept Enbrel 59 desvenlafaxine succinate 59 PRADAXA #mg 59 ProSavin 59 Celsentri Selzentry 59 thrombocytosis 59 Marfan mice 59 Cognitive impairment 59 candidemia 59 fluvastatin 59 Prostatitis 59 NPH insulin 59 receiving XGEVA 59 prodromal symptoms 59 serum phosphorous 59 post surgical adhesions 59 preoperative chemotherapy 59 smoldering multiple myeloma 59 imipramine 59 serum calcium 59 cardiovascular hospitalization 59 zotarolimus 59 vascular inflammation 59 choroidal neovascularization 59 variceal bleeding 59 postmenopausal hormone therapy 59 nephrotoxic 59 Atacand 59 frequent awakenings 59 Carvedilol 59 plasma cortisol 59 daytime drowsiness 59 renoprotective 59 mecamylamine 59 estrogen progestin therapy 59 precancerous condition 59 darapladib 59 coadministration 59 RSD# oral 59 nicardipine 59 LAF# 59 fructose intake 59 Doxil ® 59 Postoperative complications 59 neutropenic 59 cisplatin resistant 59 gastric acidity 59 inhaled iloprost 59 ALA PDT 59 dalteparin 59 angiotensin receptor blockers 59 plasma homocysteine levels 59 tHcy 59 ritonavir boosted 59 acarbose 59 venlafaxine XR 59 conventional antipsychotics 59 lomitapide 59 angiographic outcomes 59 nonfatal MI 59 semagacestat 59 blastic phase 59 Pseudomonas aeruginosa infections 59 chlamydial infection 59 motor neuron degeneration 59 fondaparinux 59 CD# upregulation 59 mycophenolate mofetil MMF 59 elevated ALT 59 Thrombotic thromboembolic complications 59 LTB4 59 neuronal dysfunction 59 zoledronate 59 antiplatelet therapies 59 sotalol 59 renal cysts 59 GI motility 59 dose cohort 59 hematologic abnormalities 59 HAART regimen 59 Menopausal hormone therapy 59 cobiprostone 59 galanin 59 bronchial hyperresponsiveness 59 PEGylated interferon beta 1a 59 chronic thromboembolic pulmonary 59 anthracycline taxane 59 virological failure 59 transaminase elevations 59 lipid lowering drugs 59 cerebral ischemia 59 skeletal metastases 59 acute decompensation 59 multivariate adjustment 59 cinacalcet 59 Taxol paclitaxel 59 metabolic parameters 59 hyperammonemia 59 nonalcoholic steatohepatitis NASH 59 somatostatin analogs 59 CsA 59 type 1diabetes 59 lenalidomide dexamethasone 59 DHEA supplementation 59 mm ³ 59 CorVue ™ 59 Subgroup analyzes 59 glucagon secretion 59 acute mania 59 XR NTX 59 asthma exacerbations 59 C1 INH deficiency 59 intestinal polyps 59 syncope fainting 59 intra ocular pressure 59 Celecoxib 59 Severe hypoglycemia 59 lipoprotein profiles 59 Hyperlipidemia 59 Daytime sleepiness 59 herpes zoster shingles 59 serum HBV DNA 59 ivabradine 59 transfusion syndrome 59 urinary tract symptoms LUTS 59 Viral load 59 memantine Namenda 59 carotid stenosis 59 diabetic gastroparesis 59 protein tyrosine phosphatase 1B 59 LAB CGRP 59 nonvertebral fracture 59 neurologic outcomes 59 weekly subcutaneous injections 59 sideeffects 59 Revascor TM 59 c reactive protein 59 paclitaxel eluting stents 59 bcr abl 59 calcineurin inhibitor 59 Abbott Trilipix 59 serum PTH 59 psoriatic arthritis PsA 59 antiandrogens 59 improves glycemic 59 beta carotene supplementation 59 TAXUS Express Stent 59 Ejection Fraction 59 allodynia 59 gastrointestinal toxicity 59 metastatic carcinoid tumors 59 Hepatocellular Carcinoma HCC 59 clinically meaningful reductions 59 thrombotic events 59 Tasimelteon 59 ULORIC 59 severe asthma exacerbations 59 iNO 59 GSK# [002] 59 azelaic acid 59 Intravenous immunoglobulin 59 pyrazinamide 59 restenosis reblockage 59 GnRH agonists 59 IUGR 59 standard chemotherapy regimen 59 microbiological eradication 59 nonvertebral fractures 59 urinary calcium excretion 59 urinary N telopeptide 59 thiazides 59 nonfasting triglycerides 59 PKC beta 59 ANAVEX #-# [001] 59 plasma pharmacokinetics 59 rhTSH 59 cerebrovascular events 59 grade cervical intraepithelial 59 aP2 59 Toxicities 59 serum potassium levels 59 HBV infections 59 alanine aminotransferase 59 isoprostane 59 antiarrhythmic drug 59 insulin sensitizing 59 lenalidomide Revlimid R 59 aneurysmal subarachnoid hemorrhage 59 advanced adenoma 59 albiglutide 59 Lp PLA 2 59 Subarachnoid hemorrhage 59 hepatic liver 59 acute aortic dissection 59 albumin excretion 59 GLP1 agonist 59 neutropenic patients 59 detectable HCV RNA 59 lumbar spine BMD 59 teriparatide 59 PDE4 inhibitors 59 neurologic sequelae 59 iPTH 59 amifostine 59 quetiapine Seroquel 59 atorvastatin #mg 59 daytime alertness 59 oxaliplatin Eloxatin 59 5-FU/LV 59 hypertrophic scars 59 neurotrophic 59 chemopreventive agent 59 glatiramer 59 hemodilution 59 Avandia Actos 59 #mg dose [001] 59 methotrexate monotherapy 59 experimentally induced 59 flow mediated dilation 59 serum testosterone 59 metaglidasen 59 paroxetine sertraline 59 elevated serum creatinine 59 Kepivance 59 digoxin toxicity 59 K ras mutations 59 BENICAR HCT 59 androgen depletion therapy 59 perioperatively 59 infliximab Remicade 59 visilizumab 59 Nexavar sorafenib 59 lung edema 59 tocilizumab 59 Inhaled nitric oxide 59 parasitemia 59 PSMA ADC 59 familial hypercholesterolemia FH 59 related hematological toxicity 59 hepatic glucose production 59 thromboembolic complications 59 lung resection 59 induced hypoglycemia 59 venous thromboembolic disease 59 sUA 59 oxcarbazepine 59 immunosuppressive regimens 59 nonmelanoma skin cancers 59 glucocorticoid hormones 59 torsade de pointes 59 mutated K ras 59 tacrolimus ointment 59 onset sepsis 59 moderately emetogenic 59 virological suppression 59 arterial thickening 59 renal cell carcinomas 59 autoimmune reactions 59 metastatic lung cancer 59 systemic bioavailability 59 MMSE scores 59 Barrett esophagus BE 59 NMDA antagonist 59 nonadherence 59 cytopenias 59 mTOR inhibition 59 tumor histology 59 HbA1C levels 59 MAO B 59 flavopiridol 59 Teriparatide 59 oral prodrug 59 acute STEMI 59 PROMACTA 59 N acetylcysteine 59 GI bleeds 59 immunosuppressive regimen 59 refractory gout 59 latanoprost 59 Roche Herceptin 59 fibrotic disease 59 dysplastic lesions 59 atopic disease 59 Febrile neutropenia 59 Folic acid supplementation 59 KRAS mutations occur 59 Lupuzor ™ 58 systolic dysfunction 58 biologic DMARD 58 Serious adverse reactions 58 anti dyslipidemic 58 Isentress raltegravir 58 bupropion SR 58 E selectin 58 CYP#A# inhibitors 58 transgene expression 58 adrenal suppression 58 graft occlusion 58 rtPA 58 FOLFOX6 58 macroalbuminuria 58 docetaxel chemotherapy 58 neointimal hyperplasia 58 heterozygous FH 58 alvespimycin 58 intracerebral haemorrhage 58 CMV infection 58 platelet stickiness 58 COREG 58 blood phenylalanine Phe 58 HNSCC 58 cortical excitability 58 B7 H3 58 statin simvastatin 58 oral antidiabetic drugs 58 sipuleucel T 58 microvessel density 58 potentiation 58 randomized Phase IIb 58 p = #.# [003] 58 Anacetrapib 58 CYP#D# genotype 58 BRIM3 58 TWYNSTA 58 urinary oxalate 58 sustained ventricular tachycardia 58 anemia neutropenia 58 hour bronchodilation 58 Helicobacter pylori eradication 58 statistically significant efficacy 58 Folate deficiency 58 plasma viremia 58 osteoclast activity 58 tiagabine 58 postmenopausal estrogen 58 tumor recurrence 58 elevated uric acid 58 ispinesib administered 58 thiazide diuretic 58 phase IIb study 58 arterial calcification 58 improves insulin sensitivity 58 esophageal motility 58 efalizumab 58 pamidronate 58 Nilotinib 58 peak plasma concentrations 58 intravenous immunoglobulin IVIg 58 STAT3 signaling 58 fluid overload 58 MMSE score 58 primidone 58 fulvestrant 58 perindopril 58 menadione 58 fasting triglycerides 58 Dapagliflozin 58 Relapsing remitting MS 58 echocardiographic parameters 58 nonnucleoside reverse transcriptase inhibitors 58 shorter telomere length 58 Effexor venlafaxine 58 haemorrhagic stroke 58 liver histology